Journal article
Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model
Abstract
To date, two published randomized trials have indicated a clinical benefit of early treatment with fluvoxamine versus placebo for adults with symptomatic COVID-19. Using the results of the largest of these trials, the TOGETHER trial, we conducted a cost-consequence analysis to assess the health system benefits of preventing progression to severe COVID-19 in outpatient populations in the United States. A decision-analytic model in the form of a …
Authors
Mills FP; Reis G; Wilson LA; Thorlund K; Forrest JI; Guo CM; Boulware DR; Mills EJ; Investigators FTT
Journal
American Journal of Tropical Medicine and Hygiene, Vol. 108, No. 1, pp. 101–106
Publisher
American Society of Tropical Medicine and Hygiene
Publication Date
January 11, 2023
DOI
10.4269/ajtmh.22-0106
ISSN
0002-9637